{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/dry-eye-syndrome/management/management/","result":{"pageContext":{"chapter":{"id":"0e301945-844e-5133-a1fa-498e54c17213","slug":"management","fullItemName":"Scenario: Management","depth":2,"htmlHeader":"<!-- begin field c7f8cf0e-2bf4-44ca-86bd-4000e9891592 --><h2>Scenario: Management of dry eye syndrome</h2><!-- end field c7f8cf0e-2bf4-44ca-86bd-4000e9891592 -->","summary":"Covers the assessment and management of dry eye syndrome.","htmlStringContent":"<!-- begin item 70a025fc-1183-4e36-a501-f430bde89531 --><!-- begin field 6768264e-81c7-4e25-aa8c-acbc015c1daf --><p>From age 10 years onwards.</p><!-- end field 6768264e-81c7-4e25-aa8c-acbc015c1daf --><!-- end item 70a025fc-1183-4e36-a501-f430bde89531 -->","topic":{"id":"386fd023-80c8-5773-9545-27347387cc3b","topicId":"19fd4567-edfc-4646-8106-bd391e9fc519","topicName":"Dry eye syndrome","slug":"dry-eye-syndrome","lastRevised":"Last revised in August 2017","chapters":[{"id":"82582060-8b99-5c66-9fef-320feddcfce7","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"4d65393d-c49d-5d93-97eb-529b725441ec","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"fdb881a7-0683-51f6-bf90-e722245af767","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"0c07d88f-cc23-5753-8b62-acea5a2111b8","slug":"changes","fullItemName":"Changes"},{"id":"9590a4e4-d362-599d-b9b5-f38d9282b1d0","slug":"update","fullItemName":"Update"}]},{"id":"dfd74917-3fbf-5b2b-9def-21fcdbfd6143","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"54ce9280-6602-5b59-9353-0f274bb0b830","slug":"goals","fullItemName":"Goals"},{"id":"1b6213cb-be33-529a-ad0b-b254fa0e8f36","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"6febc8d3-da2c-5312-b77b-a81a02506f5f","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"58e7562c-bc9e-50f5-bc0b-04965c0355ac","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"232a2da6-5403-5f0d-8a60-6f2f0c4ea0ae","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"ba9792a1-acb9-5b96-b150-e23871600eb9","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"a9ef0321-8ab7-5348-9b6b-c66ff0b06158","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"8cf72d58-fb99-5b60-84d3-24b79f1d7464","slug":"definition","fullItemName":"Definition"},{"id":"66b0cb58-895d-580a-bbe5-5e162cecbef6","slug":"causes","fullItemName":"Causes"},{"id":"34c2a996-2361-578e-9016-983d6557b01f","slug":"prevalence","fullItemName":"Prevalence"},{"id":"1cb59582-b6a7-52c5-afe8-b83bad40c0c3","slug":"prognosis","fullItemName":"Prognosis"},{"id":"70544490-0068-5332-ae85-3e602aa5ed38","slug":"complications","fullItemName":"Complications"}]},{"id":"65ed7852-6bae-5308-97f4-d5c274ff7161","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"e0075104-686c-5823-8eb6-d07250f57544","slug":"clinical-features","fullItemName":"Clinical features"},{"id":"42d15621-838d-5965-a184-63b4dcec2552","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"f1e7b678-059a-551d-9f3f-cdfb2881cedf","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"42d69539-0332-50ba-91b1-30550bdb1bc8","fullItemName":"Management","slug":"management","subChapters":[{"id":"0e301945-844e-5133-a1fa-498e54c17213","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"8ecdaf09-c71f-5c15-b953-0b250cd5705e","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"7f2c12fa-faad-58ab-998a-3c58cd44f955","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"a446bbd9-eb6d-5a79-9cab-321b94492137","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"a9551351-ae9f-52e3-9fd8-b19d329a12ac","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"25984af0-631e-5b5e-8366-c2a6a53ffce8","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"2db358b8-f9a6-5529-8314-857008167af9","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"c6d15bc0-1daf-5ba8-80b8-d08bbbb68018","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"5294e757-85ba-5226-8535-c8bd7ba1a467","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"42d69539-0332-50ba-91b1-30550bdb1bc8","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"a41879f0-0f04-5add-981c-a976ebe82b69","slug":"referral","fullItemName":"Referral","depth":3,"htmlHeader":"<!-- begin field 53b82114-3481-4894-9584-91180d7e3039 --><h3>When should I refer a person with suspected dry eye syndrome to secondary care?</h3><!-- end field 53b82114-3481-4894-9584-91180d7e3039 -->","summary":null,"htmlStringContent":"<!-- begin item 09a3529b-86c8-4b23-9986-341b9957f1d9 --><!-- begin field 9aa2330b-20e0-471b-bb2a-14dc48b8e1fb --><ul><li>Arrange same day assessment by ophthalmology if the person is suspected of having a serious eye condition such as acute glaucoma, keratitis, iritis or corneal ulcer — for further information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/red-eye/\">Red eye</a>.<ul><li>Urgent referral to ophthalmology is required for children with any corneal change.</li></ul></li><li>Arrange referral to ophthalmology or the appropriate medical speciality (with urgency depending on clinical judgement) if the person:<ul><li>Is suspected of having an <a class=\"topic-reference internal-reference\" href=\"/topics/dry-eye-syndrome/diagnosis/diagnosis/\">underlying systemic condition</a> such as Sjogren’s syndrome.</li><li>Has persistent symptoms that do not respond to <a class=\"topic-reference internal-reference\" href=\"/topics/dry-eye-syndrome/management/management/#management-in-primary-care\">underlying systemic condition</a> after 12 weeks.</li><li>Has abnormal lid anatomy or function.</li></ul></li><li>Discuss with, or refer to, ophthalmology (with urgency depending on clinical judgement) if uncertain of diagnosis.<ul><li>Have a low threshold for referral of younger people with dry eye symptoms.</li></ul></li></ul><!-- end field 9aa2330b-20e0-471b-bb2a-14dc48b8e1fb --><!-- end item 09a3529b-86c8-4b23-9986-341b9957f1d9 -->","subChapters":[{"id":"fd4f372c-e688-5471-b85f-7a9de4ebcac3","slug":"basis-for-recommendation-2eb","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 6d8a5c64-98b0-486f-afe3-ddc3a96c6054 --><h4>Basis for recommendation</h4><!-- end field 6d8a5c64-98b0-486f-afe3-ddc3a96c6054 -->","summary":null,"htmlStringContent":"<!-- begin item 2eb989cb-1e3b-47ba-b19d-d22e9d54cc6d --><!-- begin field 1c90ca2f-572d-4aad-8a43-4251abdae1dd --><p>The recommendations on when to refer a person with suspected dry eye syndrome to secondary care are based on the clinical guidelines <em>Dry eye syndrome Preferred Practice Pattern 2013</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dry-eye-syndrome/references/\">American Academy of Ophthalmology, 2013</a>], <em>National dry eye disease guidelines for Canadian optometrists. Screening, diagnosis and management of dry eye disease: practical guidelines for Canadian optometrists</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dry-eye-syndrome/references/\">Prokopich, 2014</a>], <em>Dry eye (keratoconjunctivitis sicca)</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dry-eye-syndrome/references/\">College of Optometrists, 2015</a>], <em>Ciclosporin for treating dry eye disease that has not improved despite treatment with artificial tears</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dry-eye-syndrome/references/\">NICE, 2015c</a>], and <em>Dry eye syndrome guidance</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dry-eye-syndrome/references/\">All Wales Medicines Strategy Group, 2016</a>], the <em>Summary benchmarks for Preferred Practice Pattern guidelines</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dry-eye-syndrome/references/\">American Academy of Ophthalmology, 2016</a>] and expert opinion in review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dry-eye-syndrome/references/\">Tong, 2012b</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dry-eye-syndrome/references/\">Messmer, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dry-eye-syndrome/references/\">BMJ Best Practice, 2016</a>].</p><ul><li>The National Institute for Health and Care Excellence (NICE) recommend that people with dry eye disease which does not respond to several drops of artificial tears per day should be referred to secondary care for consideration of specialist treatment such as ciclosporin or corticosteroids [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dry-eye-syndrome/references/\">NICE, 2015c</a>].</li></ul><!-- end field 1c90ca2f-572d-4aad-8a43-4251abdae1dd --><!-- end item 2eb989cb-1e3b-47ba-b19d-d22e9d54cc6d -->","subChapters":[]}]},{"id":"1deb7438-2fdc-54e4-94b3-3143f4d83923","slug":"management-in-primary-care","fullItemName":"Management in primary care","depth":3,"htmlHeader":"<!-- begin field 631bfd5f-7f5b-4649-b6e6-9ce6ec309f17 --><h3>How should I manage a person with suspected dry eye syndrome in primary care?</h3><!-- end field 631bfd5f-7f5b-4649-b6e6-9ce6ec309f17 -->","summary":null,"htmlStringContent":"<!-- begin item 10f9a50b-557f-497f-8891-8632be6880c9 --><!-- begin field 44771ba5-4ec5-4055-bce1-aad3bf13b27a --><p>If there are no red flags for a serious condition and the person does not need referral to secondary care:</p><ul><li>Educate the person on the chronic nature of the condition and explain that treatment is long term to ensure realistic treatment expectations.</li><li>Recommend lifestyle measures such as:<ul><li>Warm compresses, lid hygiene and massage — these can be especially helpful if blepharitis or Meibomian gland dysfunction are present. For more information on eyelid hygiene see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/blepharitis/\">Blepharitis</a>.</li><li>Modification of contact lens wear:<ul><li>Contact lens wear should be limited to shorter periods and lenses removed when dry eye symptoms appear — changing lens type or solution may help.</li></ul></li><li>Environmental modification — advise the person to:<ul><li>Increase relative humidity and avoid prolonged periods of computer use or time in air conditioned environments, if possible.</li><li>Lower computer screens to below eye level (decreasing lid aperture), take regular breaks, and increase blink frequency with computer use and reading.</li><li>Avoid alcohol and exposure to cigarette smoke.</li></ul></li><li>Avoidance of keratorefractive surgery, if possible — keratorefractive surgery (particularly LASIK [laser-assisted in situ keratomileusis] in people with pre-existing dry eye disease, may worsen dry eye syndrome.</li></ul></li><li>If clinically appropriate, consider alternatives to <a class=\"topic-reference internal-reference\" href=\"/topics/dry-eye-syndrome/background-information/causes/\">medication that may exacerbate dry eye syndrome</a>.</li><li>Optimise management of associated ocular or systemic conditions such as:<ul><li>Allergic conjunctivitis — for further information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/conjunctivitis-allergic/\">Conjunctivitis - allergic</a>.</li><li>Blepharitis — for further information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/blepharitis/\">Blepharitis</a>.</li><li>Rosacea — for further information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/rosacea/\">Rosacea - acne</a>.</li><li>Sleep apnoea — for further information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/obstructive-sleep-apnoea-syndrome/\">Obstructive sleep apnoea syndrome</a>.</li></ul></li><li>Recommend use of tear supplements (sometimes called artificial tears or lubricant eye drops) if lifestyle measures do not relieve symptoms.<ul><li>A large range of tear replacement and ocular lubricant products are available on prescription or over the counter. For a complete list of products available in the UK, see the British National Formulary (<a data-hyperlink-id=\"029696bb-e660-4728-9a36-a93100c32d5b\" href=\"https://bnf.nice.org.uk/\" target=\"_blank\">BNF</a>).</li><li>Drops are best for daytime use with ointments or gels reserved for use before bed as these are most likely to cause temporary blurring of vision. Less viscous formulations are less likely to cause stinging and burning.<ul><li>Hypromellose is the most frequently used preparation and may need to be instilled every hour until symptoms improve, then frequency can be reduced.</li></ul></li><li>Consider preservative free formulations if; the person is intolerant of preservative in tear supplements; has moderate to severe dry eye disease requiring drops more than 4 times per day; is using multiple preserved topical medications; or uses soft or hybrid contact lens.</li></ul></li><li>Provide patient information on dry eye syndrome — Patient information is available from:<ul><li> NHS A-Z \"<a data-hyperlink-id=\"1e091e93-0b1b-4373-96f8-a93100c32d72\" href=\"https://www.nhs.uk/conditions/dry-eyes/\" target=\"_blank\">Dry eye syndrome</a>\".</li><li>The Royal College of Ophthalmologists \"<a data-hyperlink-id=\"c501491d-7edb-4713-abef-a93100c32d86\" href=\"http://www.rcophth.ac.uk/wp-content/uploads/2015/04/Understanding-Dry-eye_final.pdf\">Understanding dry eye</a>\".</li></ul></li><li>Arrange follow up within 4–6 weeks of initiating treatment.<ul><li>If symptoms are not relieved with the initial formulation try a different product or consider adding transient gels or hypo-osmolar eye drops containing hyaluronate and lipids.</li><li>If symptoms fail to respond to treatment in primary care after 12-16 weeks <a class=\"topic-reference internal-reference\" href=\"/topics/dry-eye-syndrome/management/management/#referral\">refer to secondary care</a>.</li></ul></li></ul><!-- end field 44771ba5-4ec5-4055-bce1-aad3bf13b27a --><!-- end item 10f9a50b-557f-497f-8891-8632be6880c9 -->","subChapters":[{"id":"98d90363-8db7-5c65-9541-1d9049a8ed0e","slug":"basis-for-recommendation-dbc","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 5f9e57be-4ee3-40a4-bd35-925df4cd2538 --><h4>Basis for recommendation</h4><!-- end field 5f9e57be-4ee3-40a4-bd35-925df4cd2538 -->","summary":null,"htmlStringContent":"<!-- begin item dbcd22f5-72ea-4aef-a3ad-bbcfb8a5139d --><!-- begin field d0b3ca03-6b25-4614-9907-326802508a6f --><p>The recommendations on the management of dry eye syndrome in primary care are based on the clinical guidelines <em>Dry eye syndrome Preferred Practice Pattern 2013</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dry-eye-syndrome/references/\">American Academy of Ophthalmology, 2013</a>], <em>National dry eye disease guidelines for Canadian optometrists. Screening, diagnosis and management of dry eye disease: practical guidelines for Canadian optometrists</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dry-eye-syndrome/references/\">Prokopich, 2014</a>], <em>Dry eye (keratoconjunctivitis sicca)</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dry-eye-syndrome/references/\">College of Optometrists, 2015</a>], and <em>Dry eye syndrome guidance</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dry-eye-syndrome/references/\">All Wales Medicines Strategy Group, 2016</a>], the <em>Summary benchmarks for Preferred Practice Pattern guidelines</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dry-eye-syndrome/references/\">American Academy of Ophthalmology, 2016</a>] and expert opinion in review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dry-eye-syndrome/references/\">Tong, 2012a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dry-eye-syndrome/references/\">Tong, 2012b</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dry-eye-syndrome/references/\">Foulks, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dry-eye-syndrome/references/\">Messmer, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dry-eye-syndrome/references/\">Drug and Therapeutics Bulletin, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dry-eye-syndrome/references/\">BMJ Best Practice, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dry-eye-syndrome/references/\">Marshall, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dry-eye-syndrome/references/\">Milner, 2017</a>].</p><h5>Lifestyle factors</h5><p>The clinical guideline <em>Dry eye syndrome Preferred Practice Pattern 2013</em> highlights the importance of addressing lifestyle factors as tear replacement used in isolation is often unsuccessful in the treatment of dry eye [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dry-eye-syndrome/references/\">American Academy of Ophthalmology, 2013</a>].</p><h5>Hot compresses</h5><ul><li>Hot compresses are central to management of dry eye associated with Meibomian gland deficiency (MGD). The melting point of lipid secretions in people with MGD is higher than those without the condition and hot compresses can improve secretion from accessory tear glands. It may be difficult to maintain a consistent daily regimen as the procedure can be time consuming [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dry-eye-syndrome/references/\">Prokopich, 2014</a>].</li></ul><h5>Environmental factors</h5><ul><li>Ambient humidity, air movement and use of computers or hand held devices contribute to dry eye disease.<ul><li>Maintaining high ambient humidity with a humidifier can improve symptoms dramatically [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dry-eye-syndrome/references/\">Prokopich, 2014</a>].</li><li>Glasses or moisture chamber goggles can be used to protect eyes against air movement by fans or wind [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dry-eye-syndrome/references/\">Prokopich, 2014</a>].</li></ul></li><li>Alcohol and exposure to cigarette smoke should be avoided [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dry-eye-syndrome/references/\">Prokopich, 2014</a>].<ul><li>Cigarette smoking has an adverse effect on the lipid layer of the precorneal tear film and tear proteins [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dry-eye-syndrome/references/\">American Academy of Ophthalmology, 2013</a>].</li><li>Pooled results from 10 studies indicate that alcohol consumption may increase the risk of dry eye syndrome but larger and longer term RCTs are needed to confirm findings [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dry-eye-syndrome/references/\">You, 2016</a>].</li></ul></li></ul><p style=\"margin-left:18.0pt;\"><strong>Medication</strong></p><ul><li>Many medications (such as antihistamines, anti-depressants, and diuretics) have drying effects on the mucous membranes of the eyes — expert opinion in a clinical guideline is that, depending on the specific clinical situation, it may be appropriate to stop the offending drug or change to an alternative [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dry-eye-syndrome/references/\">Prokopich, 2014</a>].</li></ul><p style=\"margin-left:18.0pt;\"><strong>Ocular lubricants</strong></p><p style=\"margin-left:18.0pt;\">Expert opinion in review articles is that ocular lubricants may help lubricate the ocular surface,  remove debris, replenish tear volume, stabilize the tear film, dilute hyperosmolar tear films, and reduce levels of pro-inflammatory mediators [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dry-eye-syndrome/references/\">Tong, 2012a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dry-eye-syndrome/references/\">Milner, 2017</a>].</p><ul><li>Ocular surface staining with rose bengal has been shown to improve by 25–33% within one month of using tears, gels or hyaluronate-based supplements [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dry-eye-syndrome/references/\">Doughty, 2009</a>].</li><li>Many preparations with variable compositions are available commercially but there is a lack of high quality comparative evidence on safety or efficacy of individual products [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dry-eye-syndrome/references/\">Foulks, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dry-eye-syndrome/references/\">Messmer, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dry-eye-syndrome/references/\">Drug and Therapeutics Bulletin, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dry-eye-syndrome/references/\">BMJ Best Practice, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dry-eye-syndrome/references/\">Pucker, 2016</a>].<ul><li>Two review articles state that most lubricants are classified as ‘health products’ and therefore proof of efficacy is generally not required for approval by regulatory agencies in order to become commercially available [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dry-eye-syndrome/references/\">Alves, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dry-eye-syndrome/references/\">Pucker, 2016</a>].</li><li>The Drugs and Therapeutics bulletin recommends that in the absence of comparative evidence it is reasonable to start with the lowest cost preparations [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dry-eye-syndrome/references/\">Drug and Therapeutics Bulletin, 2016</a>].</li><li>Preservative-free formulations are much more expensive and the recommendation from clinical guidelines [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dry-eye-syndrome/references/\">Prokopich, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dry-eye-syndrome/references/\">All Wales Medicines Strategy Group, 2016</a>] and expert opinion in review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dry-eye-syndrome/references/\">Tong, 2012a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dry-eye-syndrome/references/\">Foulks, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dry-eye-syndrome/references/\">Drug and Therapeutics Bulletin, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dry-eye-syndrome/references/\">Milner, 2017</a>] is that if a person requires ocular lubricants more than 4 times a day or the person is using other ocular topical medications, a non-preserved product should be considered to reduce the risk of toxic adverse effects on the ocular surface.</li><li>Products with an increased viscosity, increase retention time but can lead to blurring of vision — expert opinion in review articles is that low-viscosity drops are best used in the daytime and higher viscosity preparations such as ointments and gels before sleep [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dry-eye-syndrome/references/\">Tong, 2012a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dry-eye-syndrome/references/\">Pucker, 2016</a>].</li></ul></li></ul><h5>Patient education</h5><ul><li>Expert opinion in clinical guidelines [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dry-eye-syndrome/references/\">American Academy of Ophthalmology, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dry-eye-syndrome/references/\">All Wales Medicines Strategy Group, 2016</a>] and review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dry-eye-syndrome/references/\">Tong, 2012a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dry-eye-syndrome/references/\">Messmer, 2015</a>] is that patient education is an important aspect of successful management of dry eye syndrome — the person should be educated about its natural history, chronicity and self-management techniques and realistic therapeutic goals set.</li></ul><h5>Follow up</h5><ul><li>The clinical guideline <em>Dry eye syndrome guidance</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dry-eye-syndrome/references/\">All Wales Medicines Strategy Group, 2016</a>] recommends that all dry eye treatment should be tried for 4–6 weeks before assessing benefit.</li></ul><!-- end field d0b3ca03-6b25-4614-9907-326802508a6f --><!-- end item dbcd22f5-72ea-4aef-a3ad-bbcfb8a5139d -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}